Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
161 | 3 | MENOPAUSE//ISOFLAVONES//TAMOXIFEN | 62578 |
552 | 2 | TAMOXIFEN//ESTROGEN RECEPTOR//AROMATASE INHIBITORS | 15141 |
9756 | 1 | RALOXIFENE//BAZEDOXIFENE//TISSUE SELECTIVE ESTROGEN COMPLEX | 1157 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | RALOXIFENE | authKW | 2080871 | 23% | 29% | 268 |
2 | BAZEDOXIFENE | authKW | 1285792 | 6% | 64% | 74 |
3 | TISSUE SELECTIVE ESTROGEN COMPLEX | authKW | 587030 | 2% | 86% | 25 |
4 | SELECTIVE ESTROGEN RECEPTOR MODULATOR | authKW | 544694 | 8% | 22% | 91 |
5 | LASOFOXIFENE | authKW | 379171 | 2% | 61% | 23 |
6 | TSEC | authKW | 360506 | 1% | 88% | 15 |
7 | CONJUGATED ESTROGENS | authKW | 229035 | 3% | 29% | 29 |
8 | MIDLIFE HLTH | address | 205324 | 1% | 54% | 14 |
9 | BREAST CANCER PREVENTION | authKW | 204555 | 2% | 29% | 26 |
10 | GAIL MODEL | authKW | 170479 | 1% | 48% | 13 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Obstetrics & Gynecology | 5378 | 21% | 0% | 243 |
2 | Oncology | 3383 | 29% | 0% | 337 |
3 | Endocrinology & Metabolism | 785 | 11% | 0% | 128 |
4 | Medicine, General & Internal | 644 | 12% | 0% | 142 |
5 | Geriatrics & Gerontology | 563 | 4% | 0% | 47 |
6 | Pharmacology & Pharmacy | 441 | 14% | 0% | 158 |
7 | Women’s Studies | 243 | 1% | 0% | 17 |
8 | Reproductive Biology | 219 | 3% | 0% | 35 |
9 | Public, Environmental & Occupational Health | 71 | 5% | 0% | 54 |
10 | Primary Health Care | 69 | 1% | 0% | 10 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MIDLIFE HLTH | 205324 | 1% | 54% | 14 |
2 | PREVENT OUTREACH PROGRAMS | 54477 | 0% | 100% | 2 |
3 | SECT CANC GENET PREVENT | 40855 | 0% | 50% | 3 |
4 | SURG ADJUVANT BREAST BOWEL PROJECT | 37077 | 1% | 17% | 8 |
5 | E BAY PHYS MED GRP | 36317 | 0% | 67% | 2 |
6 | CANC PREVENT GENET | 31565 | 1% | 8% | 14 |
7 | AGEING WOMEN PROJECT | 27239 | 0% | 100% | 1 |
8 | ANTHROPOL INVEST | 27239 | 0% | 100% | 1 |
9 | BAYLOR CANC | 27239 | 0% | 100% | 1 |
10 | BESINS INT | 27239 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 36163 | 5% | 2% | 56 |
2 | CLIMACTERIC | 8861 | 2% | 2% | 19 |
3 | MATURITAS | 8571 | 3% | 1% | 34 |
4 | JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 4358 | 2% | 1% | 22 |
5 | BREAST CANCER RESEARCH AND TREATMENT | 4179 | 3% | 0% | 34 |
6 | CANCER PREVENTION RESEARCH | 3070 | 1% | 1% | 12 |
7 | BREAST CANCER RESEARCH | 2711 | 1% | 1% | 15 |
8 | BREAST JOURNAL | 1984 | 1% | 1% | 9 |
9 | JOURNAL OF WOMENS HEALTH | 1732 | 1% | 1% | 12 |
10 | MEDSCAPE WOMENS HEALTH | 1699 | 0% | 3% | 2 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RALOXIFENE | 2080871 | 23% | 29% | 268 | Search RALOXIFENE | Search RALOXIFENE |
2 | BAZEDOXIFENE | 1285792 | 6% | 64% | 74 | Search BAZEDOXIFENE | Search BAZEDOXIFENE |
3 | TISSUE SELECTIVE ESTROGEN COMPLEX | 587030 | 2% | 86% | 25 | Search TISSUE+SELECTIVE+ESTROGEN+COMPLEX | Search TISSUE+SELECTIVE+ESTROGEN+COMPLEX |
4 | SELECTIVE ESTROGEN RECEPTOR MODULATOR | 544694 | 8% | 22% | 91 | Search SELECTIVE+ESTROGEN+RECEPTOR+MODULATOR | Search SELECTIVE+ESTROGEN+RECEPTOR+MODULATOR |
5 | LASOFOXIFENE | 379171 | 2% | 61% | 23 | Search LASOFOXIFENE | Search LASOFOXIFENE |
6 | TSEC | 360506 | 1% | 88% | 15 | Search TSEC | Search TSEC |
7 | CONJUGATED ESTROGENS | 229035 | 3% | 29% | 29 | Search CONJUGATED+ESTROGENS | Search CONJUGATED+ESTROGENS |
8 | BREAST CANCER PREVENTION | 204555 | 2% | 29% | 26 | Search BREAST+CANCER+PREVENTION | Search BREAST+CANCER+PREVENTION |
9 | GAIL MODEL | 170479 | 1% | 48% | 13 | Search GAIL+MODEL | Search GAIL+MODEL |
10 | SERMS | 163821 | 3% | 16% | 38 | Search SERMS | Search SERMS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |